BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 14, 2020
View Archived Issues
Starving out Chlamydia
Read More
First-in-human study of KCP-506 approved in Netherlands
Read More
Nirsevimab prevents RSV-associated lower respiratory tract infections in preterm infants
Read More
Multiple sclerosis drug prevents HIV infection in vitro
Read More
Applied StemCell receives NIH grant to advance its TARGATT technology
Read More
Prometheus and Falk enter global collaboration agreement to develop and commercialize PR-600
Read More
Minghui Pharmaceutical discovers nucleoside derivatives
Read More
New MNK1 and MNK2 inhibitors identified at Novostar Pharmaceuticals
Read More
Jiangsu Hansoh Pharmaceutical Group, Shanghai Hansoh Biomedical patent JAK-2, TYK2 inhibitors
Read More
SCO-267 improves liver parameters in a mouse model of NAFLD
Read More
Exelixis synthesizes new AXL and/or MERTK inhibitors
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical Group presents AKT inhibitors
Read More
New PTP-2C inhibitors disclosed by Betta Pharmaceuticals
Read More
Theralase re-initiates phase II study of TLD-1433 in Canada
Read More
Healx enters a new partnership to accelerate development of therapeutics for Angelman Syndrome
Read More
First patient recruited in phase II study of ASN-002 in combination with vismodegib
Read More
Clinical improvement seen with anti-MASP-2 monoclonal antibody narsoplimab in COVID-19 patients
Read More
Debiopharm presents 3-year follow-up data from phase II study of Debio-1143
Read More
Ad26.COV2.S vaccine provides robust protection against SARS-CoV-2 in rhesus macaques
Read More